Adult coats' disease successfully managed with the dexamethasone intravitreal implant (Ozurdex®) combined with retinal photocoagulation

Case Reports in Ophthalmology

Volumn 3, Issue 1, 2012, Pages 123-127

  Martínez Castillo, Sebastián ^a   Gallego Pinazo, Roberto ^a   Dolz Marco, Rosa ^a   Marín Lambíes, Cristina ^a   Díaz Llopis, Manuel ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Coats' disease; Dexamethasone intravitreal implant (Ozurdex ); Retinal telangiectasis; Retinal vasoproliferative tumor

Indexed keywords

DEXAMETHASONE;

ADULT; ANTERIOR EYE SEGMENT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ECHOGRAPHY; EXUDATE; EXUDATIVE RETINITIS; EYE EXAMINATION; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LASER COAGULATION; LIPID STORAGE; PATIENT REFERRAL; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA DISEASE; RETINA MACULOPATHY; RETINA SURGERY; RETINAL TELANGIECTASIA; RETINAL VASOPROLIFERATIVE TUMOR; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 84860704437     PISSN: None     EISSN: 16632699     Source Type: Journal    
DOI: 10.1159/000337481     Document Type: Article

References (14)

1. Coats G: Forms of retinal diseases with massive exudation. Roy Lond Ophthalmol Hosp Rep 1908;17:440-525.
2. Smithen LM, Brown GC, Brucker AJ, Yannuzzi LA, Klais CM, Spaide RF: Coats' disease diagnosed in adulthood. Ophthalmology 2005;112:1072-1078.
3. Bergstrom CS, Hubbard GB 3rd: Combination intravitreal triamcinolone injection and cryotherapy for exudative retinal detachments in severe Coats disease. Retina 2008;28(3 suppl):S33-S37.
4. Othman IS, Moussa M, Bouhaimed M: Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications. Br J Ophthalmol 2010;94:606-610.
5. Venkatesh P, Mandal S, Garg S: Management of Coats disease with bevacizumab in 2 patients. Can J Ophthalmol 2008;43:245-246.
6. Goel N, Kumar V, Seth A, Raina UK, Ghosh B: Role of intravitreal bevacizumab in adult onset Coats' disease. Int Ophthalmol 2011;31:183-190.
7. Diago T, Valls B, Pulido JS: Coats' disease associated with muscular dystrophy treated with ranibizumab. Eye (Lond) 2010;24:1295-1296.
8. Woods AC, Duke JR: Coats' disease. I. Review of literature, diagnostic criteria, clinical findings and plasma lipid studies. Br J Ophthalmol 1963;47:385-412.
9. Shields JA, Shields CL, Honavar SG, Demirci H: Clinical variations and complications of Coats disease in 150 cases. The 2000 Sanford Gifford Memorial Lecture. Am J Ophthalmol 2001;131:561-571.
10. Tamura H, Miyamoto K, Kiryu J, Miyahara S, Katsuta H, Hirose F, Musashi K, Yoshimura N: Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 2005;46:1440-1444.
11. Lim WK, Nussenblatt RB, Chan CC: Immunopathologic features of inflammatory coats disease. Arch Ophthalmol 2005;123:279-281.
12. Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group: Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 2010;117:1134-1146.e3.
13. Boyer DS, Faber D, Gupta S, Patel SS, Tabandeh H, Li XY, Liu CC, Lou J, Whitcup SM; for the Ozurdex CHAMPLAIN Study Group: Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011;31:915-923.
14. Lowder C, Belfort R Jr, Lightman S, Foster CS, Robinson MR, Schiffman RM, Li XY, Cui H, Whitcup SM; Ozurdex HURON Study Group: Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011;129:545-553.